NxStage Medical Company Profile (NASDAQ:NXTM)

About NxStage Medical

NxStage Medical logoNxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center. The System One segment is engaged in the sale and rental of the System One and PureFlow SL dialysate preparation equipment, and the sale of disposable products in the home and critical care markets. The In-Center segment is engaged in the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease (ESRD) patients at dialysis clinics, and needles for apheresis. The Services segment offers dialysis services provided to patients at its NxStage Kidney Care dialysis centers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NXTM
  • CUSIP: 67072V10
Key Metrics:
  • Previous Close: $23.46
  • 50 Day Moving Average: $24.13
  • 200 Day Moving Average: $21.06
  • 52-Week Range: $64,562,000.00 - $13.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1,173.00
  • P/E Growth: -10.23
  • Market Cap: $1.51B
  • Outstanding Shares: 64,562,000
  • Beta: 0.41
  • Net Margins: -2.06%
  • Return on Equity: -3.79%
  • Return on Assets: -2.38%
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 3.02%
  • Quick Ratio: 2.10%
Additional Links:
Companies Related to NxStage Medical:

Analyst Ratings

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Sell Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $26.33 (12.25% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
DateFirmActionRatingPrice TargetDetails
9/15/2016Northland SecuritiesSet Price TargetBuy$25.00View Rating Details
8/7/2016BTIG ResearchReiterated RatingBuy$29.00View Rating Details
8/5/2016Jefferies GroupBoost Price TargetBuy$24.00 -> $27.00View Rating Details
8/2/2016Canaccord GenuityBoost Price TargetBuy$22.00 -> $26.00View Rating Details
6/3/2016Piper Jaffray Cos.Reiterated RatingBuy$21.00View Rating Details
5/5/2016Wells Fargo & Co.Reiterated RatingSellView Rating Details
12/11/2015Sterne Agee CRTInitiated CoverageBuyView Rating Details
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for NxStage Medical (NASDAQ:NXTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.04)($0.03)$89.44 million$92.20 millionViewN/AView Earnings Details
5/4/2016Q116($0.05)($0.02)$88.40 million$89.20 millionViewListenView Earnings Details
2/10/2016Q415($0.04)($0.04)$86.83 million$89.80 millionViewListenView Earnings Details
11/3/2015Q315($0.08)($0.03)$82.06 million$86.50 millionViewN/AView Earnings Details
8/6/2015Q215($0.10)($0.08)$79.89 million$80.30 millionViewListenView Earnings Details
5/6/2015Q115($0.11)($0.09)$77.92 million$79.50 millionViewListenView Earnings Details
2/26/2015Q414($0.10)($0.08)$75.75 million$79.90 millionViewListenView Earnings Details
11/6/2014Q3($0.13)($0.11)$71.83 million$75.30 millionViewN/AView Earnings Details
8/7/2014Q214($0.11)($0.12)$70.52 million$74.10 millionViewN/AView Earnings Details
5/8/2014Q114($0.11)($0.09)$69.44 million$72.20 millionViewN/AView Earnings Details
2/27/2014Q413($0.09)($0.08)$67.66 million$69.40 millionViewN/AView Earnings Details
11/7/2013Q313$0.22($0.08)$124.03 million$66.90 millionViewListenView Earnings Details
7/25/2013Q2 2013($0.07)($0.06)$64.66 million$65.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.08)($0.08)$61.14 million$61.60 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.05)($0.04)$63.54 million$65.00 millionViewN/AView Earnings Details
11/8/2012Q312($0.06)($0.04)$60.90 million$61.00 millionViewN/AView Earnings Details
8/8/2012($0.09)($0.09)ViewN/AView Earnings Details
5/8/2012($0.09)($0.09)ViewN/AView Earnings Details
2/29/2012($0.09)($0.08)ViewN/AView Earnings Details
11/3/2011($0.10)($0.10)ViewN/AView Earnings Details
8/3/2011($0.10)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NxStage Medical (NASDAQ:NXTM)
Current Year EPS Consensus Estimate: $-0.13 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.06)($0.04)($0.05)
Q2 20164($0.07)($0.04)($0.05)
Q3 20165($0.04)$0.01($0.02)
Q4 20164($0.03)$0.00($0.02)
Q1 20172($0.01)($0.01)($0.01)
Q2 20172$0.00$0.00$0.00
Q3 20173$0.00$0.01$0.00
Q4 20173$0.00$0.02$0.01
Q1 20181$0.04$0.04$0.04
Q2 20181$0.05$0.05$0.05
(Data provided by Zacks Investment Research)


Dividend History for NxStage Medical (NASDAQ:NXTM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NxStage Medical (NASDAQ:NXTM)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 98.26%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2016Craig W MooreDirectorSell3,000$23.31$69,930.00View SEC Filing  
5/12/2016Joseph E Turk JrPresidentSell1,500$17.89$26,835.00View SEC Filing  
5/10/2016Joseph E Turk JrPresidentSell1,057$18.00$19,026.00View SEC Filing  
4/21/2016Joseph E Turk JrPresidentSell2,000$15.73$31,460.00View SEC Filing  
4/14/2016Winifred L SwanSVPSell6,260$16.40$102,664.00View SEC Filing  
4/5/2016Joseph E Turk JrPresidentSell2,500$15.05$37,625.00View SEC Filing  
3/22/2016Joseph E Turk JrPresidentSell2,000$14.34$28,680.00View SEC Filing  
3/14/2016Winifred L SwanSVPSell620$15.69$9,727.80View SEC Filing  
3/10/2016Joseph E Turk JrPresidentSell2,500$15.58$38,950.00View SEC Filing  
2/24/2016Barry M StraubeDirectorBuy1,500$14.20$21,300.00View SEC Filing  
2/24/2016Joseph E Turk JrPresidentSell2,992$14.12$42,247.04View SEC Filing  
2/16/2016Winifred L. SwanSVPSell2,500$14.07$35,175.00View SEC Filing  
2/12/2016Earl R. LewisDirectorBuy21,000$14.63$307,230.00View SEC Filing  
2/10/2016Joseph E. Turk, Jr.PresidentSell991$16.25$16,103.75View SEC Filing  
2/9/2016Joseph E. Turk, Jr.PresidentSell2,500$16.88$42,200.00View SEC Filing  
2/4/2016Joseph E. Turk, Jr.PresidentSell991$19.60$19,423.60View SEC Filing  
1/20/2016Joseph E Turk JrPresidentSell2,000$18.75$37,500.00View SEC Filing  
1/14/2016Winifred L. SwanSVPSell620$19.04$11,804.80View SEC Filing  
1/11/2016Matthew W. TowseSVPSell3,472$20.40$70,828.80View SEC Filing  
1/8/2016Joseph E. Turk, Jr.PresidentSell1,500$21.03$31,545.00View SEC Filing  
1/7/2016Joseph E. Turk, Jr.PresidentSell3,713$20.78$77,156.14View SEC Filing  
12/22/2015Joseph E. Turk, Jr.PresidentSell5,000$20.92$104,600.00View SEC Filing  
12/16/2015Joseph E. Turk, Jr.PresidentSell800$19.99$15,992.00View SEC Filing  
12/15/2015Matthew W. TowseSVPSell2,863$19.51$55,857.13View SEC Filing  
12/14/2015Winifred L. SwanSVPSell2,500$18.90$47,250.00View SEC Filing  
12/10/2015Jeffrey H. BurbankCEOSell9,274$18.94$175,649.56View SEC Filing  
12/8/2015Joseph E. Turk, Jr.PresidentSell2,913$19.38$56,453.94View SEC Filing  
11/20/2015Craig W MooreDirectorSell1,000$20.00$20,000.00View SEC Filing  
11/19/2015Joseph E Turk JrPresidentSell2,000$19.65$39,300.00View SEC Filing  
11/18/2015Craig W MooreDirectorSell4,000$19.60$78,400.00View SEC Filing  
11/16/2015Winifred L. SwanSVPSell2,500$19.65$49,125.00View SEC Filing  
11/12/2015Joseph E. Turk, Jr.PresidentSell4,055$20.44$82,884.20View SEC Filing  
11/10/2015Jeffrey H. BurbankCEOSell10,000$20.75$207,500.00View SEC Filing  
11/10/2015Joseph E. Turk, Jr.PresidentSell7,500$21.03$157,725.00View SEC Filing  
11/10/2015Matthew W. TowseSVPSell2,863$20.32$58,176.16View SEC Filing  
11/9/2015Daniel A GianniniDirectorSell6,593$20.30$133,837.90View SEC Filing  
11/9/2015Jeffrey H. BurbankCEOSell10,000$20.32$203,200.00View SEC Filing  
11/4/2015Joseph E. Turk, Jr.PresidentSell4,826$19.62$94,686.12View SEC Filing  
11/4/2015Matthew W. TowseSVPSell8,591$19.50$167,524.50View SEC Filing  
11/3/2015Robert S. BrowninsiderSell44,400$19.00$843,600.00View SEC Filing  
10/20/2015Joseph E. Turk, Jr.PresidentSell2,000$15.80$31,600.00View SEC Filing  
10/16/2015Jeffrey H. BurbankCEOSell10,000$15.59$155,900.00View SEC Filing  
10/15/2015Jeffrey H. BurbankCEOSell10,000$14.98$149,800.00View SEC Filing  
10/14/2015Winifred L. SwanSVPSell2,500$15.46$38,650.00View SEC Filing  
10/8/2015Joseph E. Turk, Jr.PresidentSell2,839$15.42$43,777.38View SEC Filing  
9/24/2015Joseph E Turk JrPresidentSell2,000$17.26$34,520.00View SEC Filing  
9/17/2015Jeffrey H. BurbankCEOSell10,000$16.18$161,800.00View SEC Filing  
9/16/2015Jeffrey H. BurbankCEOSell10,000$15.99$159,900.00View SEC Filing  
9/15/2015Craig W MooreDirectorSell1,000$16.00$16,000.00View SEC Filing  
9/14/2015Winifred L. SwanSVPSell2,500$16.01$40,025.00View SEC Filing  
9/9/2015Joseph E. Turk, Jr.PresidentSell2,839$16.54$46,957.06View SEC Filing  
8/25/2015Joseph E Turk JrPresidentSell2,000$18.25$36,500.00View SEC Filing  
8/17/2015Robert S BrownInsiderSell10,825$18.30$198,097.50View SEC Filing  
8/14/2015Winifred L SwanSVPSell2,500$18.14$45,350.00View SEC Filing  
8/13/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
8/12/2015Jeffrey H BurbankCEOSell10,000$18.03$180,300.00View SEC Filing  
8/12/2015Joseph E Turk JrPresidentSell3,252$17.74$57,690.48View SEC Filing  
7/22/2015Joseph E Turk JrPresidentSell2,000$13.86$27,720.00View SEC Filing  
7/14/2015Winifred L SwanSVPSell2,500$14.71$36,775.00View SEC Filing  
6/23/2015Joseph E Turk JrPresidentSell2,000$15.36$30,720.00View SEC Filing  
6/18/2015Jeffrey H BurbankCEOSell20,000$15.56$311,200.00View SEC Filing  
6/15/2015Winifred L SwanSVPSell2,500$15.48$38,700.00View SEC Filing  
6/10/2015Joseph E Turk JrPresidentSell2,839$16.00$45,424.00View SEC Filing  
5/18/2015Winifred L SwanSVPSell2,500$16.65$41,625.00View SEC Filing  
5/12/2015Jeffrey H BurbankCEOSell10,000$16.44$164,400.00View SEC Filing  
4/21/2015Joseph E Turk JrPresidentSell1,950$18.40$35,880.00View SEC Filing  
4/17/2015Jeffrey H BurbankCEOSell10,000$18.08$180,800.00View SEC Filing  
4/16/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
4/8/2015Joseph E Turk JrPresidentSell1,500$18.34$27,510.00View SEC Filing  
3/26/2015Joseph E Turk JrPresidentSell1,150$16.94$19,481.00View SEC Filing  
3/18/2015Jeffrey H BurbankCEOSell20,000$17.40$348,000.00View SEC Filing  
3/10/2015Joseph E Turk JrPresidentSell1,500$16.44$24,660.00View SEC Filing  
2/25/2015Joseph E Turk JrPresidentSell2,082$17.88$37,226.16View SEC Filing  
1/27/2015Joseph E Turk JrPresidentSell2,350$18.70$43,945.00View SEC Filing  
1/14/2015Winifred L SwanSVPSell500$18.44$9,220.00View SEC Filing  
1/13/2015Joseph E Turk JrPresidentSell1,500$18.35$27,525.00View SEC Filing  
1/13/2015Winifred L SwanSVPSell666$18.35$12,221.10View SEC Filing  
12/29/2014Winifred L SwanSVPSell667$18.17$12,119.39View SEC Filing  
12/23/2014Joseph E Turk JrPresidentSell2,350$18.44$43,334.00View SEC Filing  
12/15/2014Joseph E Turk JrPresidentSell2,000$17.45$34,900.00View SEC Filing  
12/15/2014Kevin HershbergerCAOSell8,000$17.19$137,520.00View SEC Filing  
12/10/2014Joseph E Turk JrPresidentSell1,500$17.77$26,655.00View SEC Filing  
12/5/2014Jeffrey H BurbankCEOSell5,000$17.16$85,800.00View SEC Filing  
12/2/2014Robert S BrownInsiderSell34,700$17.44$605,168.00View SEC Filing  
12/1/2014Joseph E Turk JrPresidentSell24,762$17.04$421,944.48View SEC Filing  
12/1/2014Winifred L SwanSVPSell16,667$17.04$284,005.68View SEC Filing  
11/25/2014Joseph E Turk JrPresidentSell3,350$17.59$58,926.50View SEC Filing  
11/14/2014Joseph E Turk JrPresidentSell29,560$17.39$514,048.40View SEC Filing  
11/14/2014Winifred L SwanSVPSell17,167$17.37$298,190.79View SEC Filing  
11/12/2014Joseph E Turk JrPresidentSell26,261$16.27$427,266.47View SEC Filing  
11/12/2014Kevin HershbergerCAOSell11,056$16.58$183,308.48View SEC Filing  
11/7/2014Joseph E Turk JrPresidentSell24,761$16.25$402,366.25View SEC Filing  
11/3/2014Joseph E Turk JrPresidentSell5,717$15.50$88,613.50View SEC Filing  
10/23/2014Joseph E Turk JrPresidentSell3,550$14.55$51,652.50View SEC Filing  
10/23/2014Robert S BrownInsiderSell45,370$14.53$659,226.10View SEC Filing  
9/24/2014Joseph E Turk JrPresidentSell3,550$13.34$47,357.00View SEC Filing  
9/19/2014Jeffrey H BurbankCEOSell2,416$14.00$33,824.00View SEC Filing  
9/19/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
9/10/2014Kevin HershbergerCAOSell843$13.58$11,447.94View SEC Filing  
9/8/2014Jeffrey H BurbankCEOSell2,322$14.00$32,508.00View SEC Filing  
9/8/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
8/27/2014Joseph E Turk JrPresidentSell2,550$13.06$33,303.00View SEC Filing  
8/15/2014Winifred L SwanSVPSell2,500$13.60$34,000.00View SEC Filing  
8/7/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
8/7/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
7/24/2014Joseph E Turk JrPresidentSell3,550$13.50$47,925.00View SEC Filing  
7/18/2014Winifred L SwanSVPSell2,000$13.46$26,920.00View SEC Filing  
6/24/2014Joseph E Turk JrPresidentSell3,950$14.43$56,998.50View SEC Filing  
6/20/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/17/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/9/2014Winifred L SwanSVPSell9,228$14.00$129,192.00View SEC Filing  
6/5/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/5/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/5/2014Winifred L SwanSVPSell7,500$14.00$105,000.00View SEC Filing  
5/29/2014Joseph E Turk JrPresidentSell4,035$13.60$54,876.00View SEC Filing  
5/15/2014Winifred SwanSVPSell9,629$12.80$123,251.20View SEC Filing  
5/14/2014Winifred SwanSVPSell5,000$13.04$65,200.00View SEC Filing  
3/6/2014Robert FunariDirectorBuy10,150$14.72$149,408.00View SEC Filing  
10/21/2013Robert S BrownInsiderSell140,100$14.00$1,961,400.00View SEC Filing  
9/9/2013Thomas SheaSVPSell1,000$12.30$12,300.00View SEC Filing  
8/12/2013Thomas SheaSVPSell1,172$12.93$15,153.96View SEC Filing  
7/8/2013Thomas SheaSVPSell7,000$14.34$100,380.00View SEC Filing  
6/10/2013Thomas SheaSVPSell5,000$13.73$68,650.00View SEC Filing  
5/13/2013Thomas SheaSVPSell15,724$12.67$199,223.08View SEC Filing  
11/13/2012David S UtterbergDirectorSell184,204$11.58$2,133,082.32View SEC Filing  
11/2/2012David S UtterbergDirectorSell34,730$11.13$386,544.90View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for NxStage Medical (NASDAQ:NXTM)
finance.yahoo.com logoNxStage Highlights Innovative Nx2me Platform Data at Partners HealthCare Connected Health Symposium & Expo 2016 (NASDAQ:NXTM)
finance.yahoo.com - October 21 at 10:01 AM
capitalcube.com logoNxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : October 12, 2016 (NASDAQ:NXTM)
www.capitalcube.com - October 12 at 11:54 AM
publicnow.com logoNxStage® to Report Third Quarter 2016 Financial Results (NASDAQ:NXTM)
www.publicnow.com - October 6 at 12:01 PM
publicnow.com logoNxStage and Satellite Healthcare Announce New Three-Year Home Hemodialysis Agreement that Includes Innovative Nx2me Platform (NASDAQ:NXTM)
www.publicnow.com - October 3 at 11:06 AM
tmcnet.com logoNxStage® to Report First Quarter 2016 Financial Results (NASDAQ:NXTM)
www.tmcnet.com - September 18 at 10:49 AM
capitalcube.com logoNxStage Medical, Inc. – Value Analysis (NASDAQ:NXTM) : September 13, 2016 (NASDAQ:NXTM)
www.capitalcube.com - September 14 at 10:48 AM
capitalcube.com logoNxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : September 12, 2016 (NASDAQ:NXTM)
www.capitalcube.com - September 12 at 11:08 AM
News IconNoteworthy Friday Option Activity: USCR, NXTM, LXRX (NASDAQ:NXTM)
www.stockoptionschannel.com - September 9 at 6:09 PM
capitalcube.com logoETF’s with exposure to NxStage Medical, Inc. : August 29, 2016 (NASDAQ:NXTM)
www.capitalcube.com - August 29 at 6:22 PM
realistinvestor.com logoHere’s The Growth Forecast For NxStage Medical, Inc. (NASDAQ:NXTM) (NASDAQ:NXTM)
www.realistinvestor.com - August 20 at 6:14 PM
nasdaq.com logoCommit To Buy NxStage Medical At $20, Earn 8.1% Annualized Using Options (NASDAQ:NXTM)
www.nasdaq.com - August 16 at 6:43 PM
finance.yahoo.com logoNXSTAGE MEDICAL, INC. Financials (NASDAQ:NXTM)
finance.yahoo.com - August 12 at 6:43 PM
finance.yahoo.com logoNxStage Launches First of Many NxGen Features and Capabilities (NASDAQ:NXTM)
finance.yahoo.com - August 8 at 11:16 AM
capitalcube.com logoNxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:NXTM)
www.capitalcube.com - August 5 at 6:46 PM
finance.yahoo.com logoEdited Transcript of NXTM earnings conference call or presentation 4-Aug-16 1:00pm GMT (NASDAQ:NXTM)
finance.yahoo.com - August 5 at 9:39 AM
fool.com logoHome and Critical Care Drive NxStage Medical, Inc. Q2 Improvement (NASDAQ:NXTM)
www.fool.com - August 4 at 2:34 PM
prnewswire.com logoNxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance (NASDAQ:NXTM)
www.prnewswire.com - August 4 at 9:46 AM
sg.finance.yahoo.com logoNxStage reports 2Q loss (NASDAQ:NXTM)
sg.finance.yahoo.com - August 4 at 9:46 AM
finance.yahoo.com logoNxStage to Present at Canaccord Genuity 36th Annual Growth Conference (NASDAQ:NXTM)
finance.yahoo.com - August 2 at 11:31 AM
finance.yahoo.com logoSt. Jude Medical (STJ) Meets Q2 Earnings, Withdraws Outlook (NASDAQ:NXTM)
finance.yahoo.com - July 21 at 9:28 AM
4-traders.com logoNxStage Medical : Macon Dialysis Center Grand Opening (NASDAQ:NXTM)
www.4-traders.com - July 21 at 9:28 AM
finance.yahoo.com logoMacon Dialysis Center Grand Opening (NASDAQ:NXTM)
finance.yahoo.com - July 21 at 8:00 AM
finance.yahoo.com logoIllumina Stock Hit by Downbeat Guidance, Stiff Competition (NASDAQ:NXTM)
finance.yahoo.com - July 8 at 10:27 AM
publicnow.com logoNxStage® to Report Second Quarter 2016 Financial Results (NASDAQ:NXTM)
www.publicnow.com - July 1 at 8:41 AM
finance.yahoo.com logoNxstage Medical upgraded by Northland Capital (NASDAQ:NXTM)
finance.yahoo.com - June 28 at 9:26 AM
biz.yahoo.com logoNXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:NXTM)
biz.yahoo.com - June 27 at 5:01 PM
prnewswire.com logoWhy Investors Love These Medical Appliances & Equipment's Stocks? - Align Technology, ZELTIQ Aesthetics, Amedica, and Nxstage Medical (NASDAQ:NXTM)
www.prnewswire.com - June 23 at 7:05 PM
capitalcube.com logoNextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 (NASDAQ:NXTM)
www.capitalcube.com - June 22 at 7:57 AM
biz.yahoo.com logoNXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:NXTM)
biz.yahoo.com - June 13 at 5:26 PM
marketnewsvideo.com logoNxStage Medical Stock Sees Short Interest Expand By 10.6% (NASDAQ:NXTM)
www.marketnewsvideo.com - June 11 at 9:27 AM
finance.yahoo.com logoNxstage Medical (NXTM) Catches Eye: Stock Jumps 5.6% (NASDAQ:NXTM)
finance.yahoo.com - June 9 at 8:40 AM
capitalcube.com logoNextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: 2015 By the Numbers : June 2, 2016 (NASDAQ:NXTM)
www.capitalcube.com - June 2 at 3:28 PM
biz.yahoo.com logoNXSTAGE MEDICAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:NXTM)
biz.yahoo.com - June 1 at 4:31 PM
News IconEarnings Review and Stock Rundown for NxStage Medical, Inc. (NASDAQ:NXTM) - Wall Street Hints and News (NASDAQ:NXTM)
hintsnewsnetwork.com - May 27 at 1:10 AM
publicnow.com logoNxStage Announces Second Quarter 2016 Investor Conference Schedule (NASDAQ:NXTM)
www.publicnow.com - May 24 at 8:06 AM
istreetwire.com logoIt's Earnings Time: What to Do with Nxstage Medical, Inc. (NASDAQ:NXTM) Stock - iStreetWire (NASDAQ:NXTM)
www.istreetwire.com - May 23 at 7:50 PM
streetinsider.com logoNxStage Medical (NXTM): Bear Thesis Has No Teeth - Piper Jaffray - StreetInsider.com (NASDAQ:NXTM)
www.streetinsider.com - May 17 at 12:01 PM
News IconNxstage Medical Incorporated (NASDAQ:NXTM) Shorted Shares Increased By 6.32% - Wall Street Hints and News (NASDAQ:NXTM)
hintsnewsnetwork.com - May 16 at 7:33 PM
streetupdates.com logoTwo Movers within Investors Observation: EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) , NxStage Medical, Inc ... - Street Updates (NASDAQ:NXTM)
www.streetupdates.com - May 16 at 1:12 PM
News IconNxStage Medical, Inc. (NXTM) President Joseph E. Turk, Jr. Sells 1057 Shares - Washington News Wire (NASDAQ:NXTM)
washingtonnewswire.com - May 11 at 8:17 PM
fidaily.com logoNxStage Medical, Inc. (NASDAQ:NXTM) Is Trading Down – Insider Trading Activity (NASDAQ:NXTM)
www.fidaily.com - May 11 at 8:17 PM
equities.com logoNxStage Medical Inc. (NXTM) Jumps 6.49% on May 09 - Equities.com (NASDAQ:NXTM)
www.equities.com - May 9 at 7:59 PM
News IconEarnings Outlook on NxStage Medical, Inc. (NASDAQ:NXTM) - B.O.D.Y Confidential (NASDAQ:NXTM)
www.bodyconfidential.com - May 5 at 8:47 PM
capitalcube.com logoNxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:NXTM)
www.capitalcube.com - May 5 at 12:32 PM
finance.yahoo.com logoEdited Transcript of NXTM earnings conference call or presentation 4-May-16 1:00pm GMT (NASDAQ:NXTM)
finance.yahoo.com - May 4 at 4:51 PM
biz.yahoo.com logoNxStage Medical Inc Earnings Call scheduled for 9:00 am ET today (NASDAQ:NXTM)
biz.yahoo.com - May 4 at 9:00 AM
biz.yahoo.com logoNXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:NXTM)
biz.yahoo.com - May 4 at 8:25 AM
sg.finance.yahoo.com logoNxStage reports 1Q loss (NASDAQ:NXTM)
sg.finance.yahoo.com - May 4 at 8:20 AM
finance.yahoo.com logo8:13 am Nxstage Medical beats by $0.03, slight beat on revs; guides Q2 revs above consensus; guides to higher end of prior FY16 revenue guidance (NASDAQ:NXTM)
finance.yahoo.com - May 4 at 8:13 AM
publicnow.com logoNxStage Reports First Quarter Financial Results (NASDAQ:NXTM)
www.publicnow.com - May 4 at 8:10 AM


NxStage Medical (NASDAQ:NXTM) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by MarketBeat.com Staff